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The  macrophage  participates  in  a  wide  variety  of important  physiological 
functions, including the recognition and destruction of tumor cells. Since many 
of these functions are mediated by the cell surface, the structural and functional 
characterization of macrophage surface components is an area of considerable 
interest and intense study (I-3).  One approach to this study involves analyzing 
alterations in macrophage surface components that occur in response to inflam- 
mation or as a consequence of activation to a tumoricidal state (1-4). Information 
obtained from studying these alterations has proven useful in identifying specific 
components  that  are  involved  in  some  of  the  specialized  surface  functions 
characteristic of the inflammatory and the activated macrophage. To date, most 
work in this area has focused on protein components of the macrophage surface, 
particularly on receptor proteins. Although much has been learned from these 
studies, other potentially important components have not been studied in detail. 
Glycolipids constitute one class of surface components for which biochemical 
data are scant. An increasingly large body of evidence indicates that glycolipids 
are important functional components of the cell surface (5);  for this reason,  it 
seems likely that glycolipids may play key roles in macrophage surface phenom- 
ena,  either by themselves,  or  in  concert with other  surface components.  The 
limited data that do exist on macrophage glycolipids, however, are fragmented 
and contradictory. For example,  there are reports  that argue both for (6)  and 
against (7) the presence on the macrophage surface of asialo GM~, a molecule of 
considerable importance,  since it  has been  implicated as a  marker  for specific 
types of cytotoxic cells (8). 
In light of the above observations we have carried out a detailed study on the 
major glycolipid constituents of the resident,  inflammatory, and tumoricidally 
activated  mouse  peritoneal  macrophage.  The  results  presented  in  this  paper 
demonstrate that the inflammatory and the activated macrophage are character- 
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Structures of the glycolipids  referred to in this paper are presented in Table I. 
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ized by alterations in the chemical amount and in the surface exposure of specific 
glycolipid species relative to the resident macrophage. 
Materials and  Methods 
Mice.  Female C57/BL6  mice obtained from The Jackson Laboratory (Bar Harbor, 
ME) at 7 wk of age were used in all experiments. 
Macrophages.  Peritoneal macrophages were obtained by lavage of the peritoneal cavity 
with 10 ml of cold phosphate-buffered saline (PBS; Ca++ and Mg++ free)  ~ containing 1 
mM Hepes buffer, pH 7.2.  Harvested peritoneal cells were centrifuged at 250 g  for 10 
rain at 4°C and resuspended in  MEM containing  10%  heat-inactivated fetal calf serum 
and 2 mM freshly prepared glutamine (normal medium). Aliquots of the peritoneal cell 
suspension (containing -107  macrophages) were plated  in  60-mm plastic tissue culture 
plates,  and  the  plates were incubated  at  37°C  for 4  h.  The plates were  then  washed 
vigorously with PBS to remove the nonadherent cells, and the macrophages were surface 
labeled as described below. 
Resident macrophages were obtained as described above, from untreated mice. ~2-3 
x  106 peritoneal cells were harvested from each mouse, of which 40-50% were macro- 
phages as determined by Wright-Giemsa staining. 
Thioglycollate  (TG)-elicited  macrophages  were  obtained  from  mice  that  had  been 
injected intraperitoneally 4 d  before sacrifice with  1.5  ml of a 4% solution of TG broth 
(Difco Laboratories, Inc., Detroit, MI) prepared according to the manufacturer's instruc- 
tions. This procedure yielded 2-3 ×  10 v peritoneal cells, of which 80-90% were macro- 
phages. 
In order to obtain bacillus Calmette-Guerin (BCG)-activated macrophages, mice were 
injected with  107 live BCG (Phipps strain  1022; Trudeau Institute, Saranac Lake, NY) 3 
wk before, and subsequently  3  d  before, sacrifice. This procedure yielded  5-6  x  106 
peritoneal cells, of which 40-50% were macrophages. 
Cytolysis  Assay.  All  populations of macrophages were tested  for their ability to lyse 
P815 cells in an 18-h Na~5~CrO4 (~Cr; New England Nuclear, Boston, MA) release assay 
as described by Russell (9). The assay was carried out in triplicate in 6-mm wells of a 96- 
well microtiter plate containing 5 X 105 adherent macrophages and 5 x  10 ~ labeled P815 
cells. The spontaneous release of 5~Cr from P815 cells during the course of the assay was 
<25% of the total label incorporated. The percent net cytolysis is defined as: [(Released 
cpm  in  experimental  wells  -  cpm  spontaneous  release)/(total  cpm  releasable  -  cpm 
spontaneous release)] x  100. The cytolysis data are presented in Table II. 
Surface Labeling.  Populations of macrophages were surface labeled by the galactose 
oxidase/NaB3H4 method (10).  Adherent  macrophages were incubated in  2  ml of PBS 
containing 30 U of galactose oxidase (Sigma Chemical Co., St. Louis, MO), for 60 min at 
4°C. The plates were washed with PBS and subsequently 2 ml of PBS containing 2 mCi 
NaB3H4 (New England Nuclear) were added to each plate. The reduction was carried out 
at 4°C for 60 min. In control experiments, the galactose oxidase incubation was omitted. 
Following the NaBSH4 reduction, the plates were washed with PBS and the macrophages 
were scraped off in cold PBS with a  Teflon scraper. The macrophage suspension was 
sonicated for 30  s at 4°C  with  a  Branson probe sonicator (model  185;  Branson  Sonic 
Power  Co.;  Danbury,  CT)  set  at  the  lowest  setting.  An  aliquot  from each  sonicated 
suspension was removed for protein assay performed by the method of Lowry (11), and 
the remaining suspension was centrifuged at  15,000 g for 10  min. The resultant pellet 
was solubilized in 10 ml of chloroform-methanol (2:1) by probe sonication. 
Glycolipid Extraction  and Analysis.  The chloroform-methanol extracts were dried un- 
der N2, resuspended in distilled water, and desahed on Bond-Elut cartridges (reference 
12;  Analytical  Chemicals,  Harbor City,  CA).  The desalted  glycolipids were chromato- 
graphed on DEAE-Sephadex A-25 (Pharmacia Inc., Piscataway, N  J) to separate neutral 
l Abbreviations used in this paper:  BCG,  bacillus Calmette-Guerin; StCr, Na2~lCrO4; HPLC, high 
pressure liquid chromatography; HRP, horseradish peroxidase; PBS, phosphate-buffered saline; TG, 
thioglycollate; TLC, thin layer chromatography. 1116  GLYCOLIPIDS  OF  THE  MOUSE PERITONEAL MACROPHAGE 
glycolipids from gangliosides (13). Neutral glycolipids were treated with 0.6 N methanolic 
NaOH for 1 h at room temperature, neutralized with HCI, and desalted. The desalted 
neutral glycolipids were chromatographed on high performance, thin layer chromatog- 
raphy (TLC) plates (E.  Merck,  Inc.,  Darmstadt,  FRG) in chloroform-methanol-water, 
60:35:8.  Gangliosides were also chromatographed on high performance TLC plates in 
chloroform-methanol-water (55:45:10) containing 0.02%  CaCI2 as described previously 
(14),  and  visualized  with resorcinol-HCl reagent.  TLC plates containing radioactively 
labeled glycolipids were exposed on ultrafilm (LKB, Bromma, Sweden) for 4-14  d  at 
room temperature. 
High Pressure Liquid Chromatography.  High pressure liquid chromatography (HPLC; 
Waters Associates, Milford, MA) analysis was carried out as described (15) on a 2.1 ×  50 
cm  Zipax column (E.  I.  DuPont de  Nemours,  Inc.,  Wilmington, DE)  with a  13-min 
gradient of 1-20%  dioxane in hexane.  UV detection at  230  nm was employed. The 
densitometric analysis was performed on the high performance TLC plates using a Zenith 
soft-laser scanning densitometer (Biomed Instruments Inc., Fullerton, CA). 
Gas-Liquid Chromatography.  Analysis of the neutral and amino sugar components of 
gangliosides was  performed by gas-liquid  chromatography as  described  (16).  Briefly, 
gangliosides were treated with 0.75 N methanolic HC! extracted in hexane, re-N-acety- 
lated, and analyzed as the Me3Si derivatives on a 3% OV-I  column with a temperature 
program of 150-250 °C. 
Sialic acids were analyzed using the same 3% OV-1  column as described (17). Briefly, 
gangliosides were treated with 0.05 N aqueous HCI for 1 h at 80°C and the products 
were converted to the MesSi derivatives. The column was run isothermally at 220°C. 
Sugar ratios were determined empirically and compared with the composition of known 
glycolipids, which were analyzed simultaneously under the same conditions. 
lmmunochromatography.  Neutral glycolipids  and gangliosides were chromatographed 
on aluminum high performance TLC plates (E.  Merck) in chloroform-methanol-water 
(60:35:8),  dried, then dipped in 0.05% polyisobutyl methacrylate in hexane as described 
by Brockhaus et al. (18). The plates were then soaked in PBS containing 1% BSA for 2 h 
before  exposure  to  either  a  rabbit  anti-asialo GM1  antibody (19),  a  rat  anti-mouse 
Forssman antigen monoclonal antibody (20), or to horseradish peroxidase (HRP) conju- 
gated  to  the ~  subunit of cholera  toxin (List Biological  Labs,  Campbell,  CA).  HRP- 
conjugated anti-rabbit or anti-rat immunoglobulins (Accurate Chemical & Scientific Corp., 
Westbury, NY) were used as second-step antibodies. The plates were developed with 33 
mM 4-chloro-l-naphthol in Tris buffer containing 2% methanol and 0.25% H~O2. 
Results 
Populations  of adherent  resident,  inflammatory, and  BCG-activated  mouse 
peritoneal macrophages were surface labeled by the galactose oxidase/NaB3H4 
method (10), and glycolipids derived from these macrophages were resolved into 
individual  species  by  high  performance  TLC  and,  in  some  cases,  by  HPLC. 
Comparisons  were  made among  the  macrophage  populations  on  the  basis  of 
types  of glycolipid  species  present,  the  relative  amounts  of these  glycolipids 
(normalized to total cellular protein), and their accessibility to labeling. 
In contrast to the standard galactose oxidase/NaB3H4 protocol (10), the entire 
procedure was carried out at 4°C to minimize the effects of membrane recycling 
on the surface labeling pattern  (21).  No  labeling of glycolipids was evident in 
any of our experiments in the absence of galactose oxidase treatment, establishing 
that the labeling observed in the presence of galactose oxidase is specifically in 
carbohydrate. In addition, no differences in the surface labeling patterns were 
observed for any given population of macrophages plated at different densities. 
Of the three populations of macrophages, only BCG-activated macrophages are 
capable of lysing P815 cells during an 18-h 51Cr- release assay (Table II). MERCURIO  ET  AL.  1 1 17 
Neutral Glycolipids.  Analyses of the neutral glycolipid fraction obtained from 
the three macrophage populations (Fig. 1  A) indicate that CMH, CDH, and asialo 
GM1 are the major constituents (see Table I for structures). The neutral glyco- 
lipids are present in very small amounts (~6.6 #g neutral glycolipid/mg protein) 
and, as a result, could not be visualized easily by TLC. They are identifiable by 
HPLC,  however, and  the data  indicate that  the amount of CMH  present is 
considerably  greater  than  that  of either  CDH  or  asialo  GMI  in  all  of the 
macrophage populations. The HPLC analyses also indicate that the TG-elicited 
macrophage contains more of these glycolipids than either the resident or BCG- 
TABLE  I 
Structures of Glycolipids 
Galactosylceramide  (CMH}  Gal-Cer 
Glucosylceramide  (CMH)  Glc-Cer 
Lactosylceramida  (CDH)  Gal(~I-~)Glc-Csr 
Globotrtaosylceramlde  (CTH)  Gal(a-l-4)Gal(~l-4)Glc-Cer 
Globotetraoa~leeramide  (Globoa£de)  GaXN&¢t~l-3)Gallal-~)Gal(~l-4)Gle-Cer 
Gangliotetraosylceramid@  (Asialo GM1)  Gal(~I-3)GalN&e(~I-q)GaI(~I-4)GIe-Cor 
Forssman  GalNAe(al-3)GalN~c(~I-3)  Gal(~l-Gal(01-q)Glc-Car 
4) 
GH3  Gal(~I-4)GIc-Cer 
3 
2 a 
NeuAe 
GM2  GaIHAc|~1-~)Ga1(~1-4)Glc-Car 
3 
2 a 
NeuAc 
GMI  Gal(~I-3)GalNAc(~I-~)Gal[~I-4)Gle-Cer 
3 
2 a 
NeuAe 
GDIa  Gal(~-3JGaiNAc(~1-~)Gal[~1-~)G1c-Cer 
3  3 
2 a  2 a 
NauAe  NeuAc 
GDIb  Gal{~J-3)GalNAc(~1-~)Gal(~1-~)Glc-Cer 
3 
2 a 
NaUAC(G2-8)NaUAC 
* Abbreviations: Gal, I>galactose;  Glc, D-glucose; GalNAc, N-acetyl-l~galactosamine;  GleNAc, N-acetyl-o-glucosamine;  Cer (ceramide), 
N-acylspbingosine. 
TABLE  II 
Cytolysis of ~tCr-labeled P815 Targets by Macrophage Populations* 
Macrophage populations  t  Net cytolysis  I 
% 
Resident  0 
TG-elicited  0 
BCG-activated  20.1 (_ 1.8)-56.0 (+ 6.0) 
*  18-h assay performed as described in Materials and Methods. 
* Macrophage populations  were obtained as described in  Materials and 
Methods. 
0 Values reported are the lowest and highest cytolysis values (+SD) ob- 
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FIGURE  1.  Chromatograms  of neutral glycolipids derived from  mouse peritoneal macro- 
phages. (A) HPLC of neutral glycolipids derived from resident, BCG-activated, and TG-elicited 
macrophages and detected by UV at 205 nm as the perbenzoyl derivates. The standard peaks 
are identified as the derivatives of: (1) globotriaosylceramide (CTH); (2) globotetraosylceram- 
ide (globoside); and (3) gangliotetraosylceramide (asialo  GM 0.  The peaks at 6  and  10  min 
correspond with ceramide monohexoside (CMH) and lactosylceramide (CDH), respectively. 
For each sample, the equivalent of 150 ~tg of cellular protein was analyzed. (B) Autoradiogram 
of a high performance thin layer chromatogram of neutral glycolipids derived from resident, 
BCG-activated, and TG-elicited macrophages surface labeled by the galactose oxidase/NaBSH4 
method. Each lane represents the equivalent of 200 ~tg of cellular protein. 
activated macrophage: the latter two populations  contain approximately equal 
amounts of these glycolipids. 
Asialo GMz  is the predominant neutral glycolipid labeled on the macrophage 
surface as shown in Fig.  1 B. Asialo GM~ is resolved into two distinct species by 
TLC (Fig.  1 B), and we have confirmed that both of these species are bona fide 
asialo GM1 by their ability to bind a rabbit anti-asialo GM1 antibody (19) as shown 
by  immunochromatograpby using  an  HRP-conjugated  second  antibody  (Fig. 
2A). Similar experiments with an anti-Forssman monoclonal antibody (20) indi- 
cate the presence of Forssman  antigen in  TG-elicited macrophages (Fig.  2B). 
Forssman antigen cannot be detected in TG-elicited macrophages by chemical 
means, including HPLC, presumably because it is present in very small amounts. 
Other  macrophage populations  have  not been  examined for  the presence of 
Forssman antigen. 
Although we consistently observed labeling of asialo GM1  on the surface of 
BCG-activated macrophages, we have never observed its labeling on the surface 
of resident macrophages (Fig.  1 B) even though, as stated above, asialo GM1  is 
present in resident macrophages in amounts equivalent to that found in BCG- 
activated macrophages. The intensity of labeling of asialo GM~ on the surface of 
TG-elicited macrophages is consistent with the increased amount of this glyco- 
lipid in these cells (Fig.  1), and it is greater than the labeling of asialo GM1  on 
the surface of BCG-activated macrophages. 
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FIGURE 2.  Immunochromatography  of neutral glycolipids  derived from TG-elicited macro- 
phages. (A) High  performance,  thin  layer chromatogram  of neutral  glycolipids from  TG- 
elicited macrophages (TG) and from a standard mixture of brain glycolipids (S) exposed to a 
rabbit  anti-asialo GMI  antibody  (19) and  visualized with an  HRP-conjugated  anti-rabbit 
immunoglobulin  as  a  second  antibody.  (/3) High  performance,  thin  layer  chromatogram 
identical to A but exposed  to  M1/87,  a  rat  anti-mouse monoclonal antibody  specific for 
Forssman antigen  (20) and HRP-conjugated anti-rat immunoglobulin. The positions of glo- 
boside, Forssman antigen, and asialo GM~ in the standard mixture are indicated. 
TLC  (Fig.  3A)  indicates  that  GM~  is  the  predominant  ganglioside  in  all  three 
macrophage  populations.  The  amount  of  ganglioside  material  in  the  mouse 
macrophage  (~ 10 #g/mg  total  cellular protein)  is considerably  greater  than  the 
amount of neutral  glycolipid. 
Three  distinct  molecular  species  have  been  ascribed  to  GMI  in  our  TLC 
separations  (denoted  1,  2,  and  3  in  Fig.  3).  The  identification  of these  three 
species as GM~ is based on their  co-migration  with standard  brain GMI (which is 
comprised  of only one  species) and,  more  importantly,  on  their  ability  to bind 
the beta subunit  of cholera  toxin conjugated  to HRP (Fig.  4).  The beta subunit 
of cholera toxin has a specific and high affinity for GM1 (22). Comparison  of the 
resorcinol  staining pattern  and the cholera toxin-HRP binding pattern  indicates 
that only two species of GMI are present  in resident  macrophages  (species 2 and 
3).  In  contrast,  three  distinct  species  are  present  in  TG-elicited  macrophages. 
BCG-activated  macrophages  also appear  to contain  these  three  GM1  species, as 
indicated  primarily  by the  surface  labeling  data  (see  below);  the  ability  of the 
first  GM1  species  in  BCG-activated  macrophages  to  bind  cholera  toxin-HRP, 
however,  is considerably  reduced  compared  with  its ability in  TG-elicited  mac- 
rophages (Fig. 4).  It is interesting  to note that there is a fourth molecular species 
that migrates with a mobility similar to GM1 in all three macrophage populations, 
but that does not bind cholera toxin-HRP.  The identity of the molecular species 
migrating  slower  than  GM~  in  the  region  of  GDla  and  GDIb  has  not  been 
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FIGURE 3.  High performance, thin layer chromatograms of gangliosides derived from mouse 
peritoneal macrophages surface labeled by the galactose oxidase/NaBSH4 method. Each lane 
represents  the  equivalent of 300  #g  of cellular protein.  (A)  Detection  of gangliosides by 
resorcinoI-HCI staining. (B) Autoradiogram of the same chromatogram exposed for 7 d. Lanes 
1 and 5 are derived from resident macrophages; lanes 2 and 6 are derived from BCG-activated 
macrophages;  lanes  3  and  7  are  derived  from  TG-elicited  macrophages;  lane  4  contains 
standard  gangliosides derived  from  bovine  brain  and  these  are  indicated  in  the  margin. 
Individual ganglioside species in the GMI region are numbered  1-4. 
FIGURE 4.  Immunochromatography of gangliosides derived from mouse peritoneal macro- 
phages. Gangiiosides from resident, BCG-activated, and TG-elicited macrophages were sepa- 
rated by high performance, thin layer chromatography and the chromatogram was exposed 
to  the  beta  subunit  of cholera  toxin  (choleragenoid)  conjugated  to  HRP.  The  HRP  was 
visualized by carrying out the peroxidase reaction. The individual GM1 species corresponding 
to those in Figs.  3 and 5 are indicated at the right. MERCURIO  ET  AL.  1 121 
To obtain additional structural information on the GM~ species present in TG- 
elicited macrophages, the region of the TLC plate containing these species was 
scraped and subjected to additional studies. Gas-liquid chromatographic analysis 
indicates  that  they contain  galactose,  glucose, and N-acetylgalactosamine  in a 
ratio of 2:1:1, substantiating the presence of GM1 (see Table I). Analysis of the 
neuraminic acid  content  of these  GM1  species  indicates  that  they contain  an 
approximately equal mixture of N-acetyl and N-glycolyl neuraminic acid. Such 
differences in neuraminic acid, as well as differences in ceramide structure, could 
contribute to the presence of distinct GM~ species. 
Interestingly, alterations in the relative chemical amounts of the GMI species 
exist among the macrophage populations (Fig. 3A). As indicated above, one of 
the  species appears  to  be  totally  absent  from  resident  macrophages and  it  is 
present only in TG-elicited and BCG-activated macrophages; moreover, this first 
GMI species is more abundant in TG-elicited macrophages than in BCG-macro- 
phages. The other major change involves the third GM~ species. This species is 
more abundant  in  TG-elicited  macrophages  than  in  either  resident  or  BCG- 
activated macrophages.  These alterations  are  readily apparent  in the densito- 
metric scan of the corresponding TLC plate (Fig. 5). 
The galactose oxidase/NaB3H4 labeling of surface gangliosides (Fig. 3B) indi- 
cates that the three species of GMt are the predominant gangliosides labeled on 
the macrophage surface, and also points out interesting differences between the 
relative  amounts  of these  species  and  their  accessibility  to galactose  oxidase/ 
NaB~H4 labeling. The differences are visualized easily by comparing the densi- 
'  j 
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FIGURE 5.  Densitometric scan  of the  GMI  region  of the  high  performance,  thin  layer 
chromatogram shown in Fig. 3.  (A) Scan of the resorcinol-HCI stained chromatogram (Fig. 
3A).  (B) Scan of the autoradiogram of this chromatogram (Fig. 3B).  The numbered peaks 
correspond to the numbered GM, species in Fig. 3. The densitometric analysis was performed 
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tometric scans of the resorcinol stain and autoradiogram of the same TLC plate 
(Fig. 5). A striking contrast is observed in the labeling of the third GM1 species 
between TG-elicited and BCG-activated macrophages. This  GM1  species is la- 
beled intensely on the surface of BCG-activated macrophages and only faintly 
on TG-elicited macrophages even though, as stated above, it is more abundant 
in TG-elicited macrophages. Both of the GM1 species present in resident mac- 
rophages are labeled intensely on the surface. No labeling of the first GM1 species 
is  evident on  resident  macrophages,  providing  additional  evidence  that  it  is 
absent from this population of macrophages. The first GM~ species is labeled on 
the surface of BCG-activated macrophages, even though it is barely detectable 
by resorcinol staining and cholera toxin binding. It is labeled prominently on the 
surface of TG-elicited macrophages. 
Discussion 
An  understanding  of  the  mechanism  by  which  macrophages  acquire  the 
capacity for the recognition and subsequent lysis of tumor cells is one of the key 
unresolved problems in macrophage cell biology. Recent studies have focused, 
in part, on alterations in surface proteins that accompany tumoricidal activation 
and on their potential functional significance (1-4). In contrast, before our work, 
little information that dealt with macrophage surface carbohydrates was available. 
The results presented in this paper are concerned with a major class of surface 
carbohydrates,  the  glycolipids.  Comparison  of populations  of resident,  TG- 
elicited, and tumoricidally activated macrophages indicates significant differences 
in the chemical amount and accessibility to galactose oxidase/NaBaH4 labeling 
of their  glycolipid constituents.  Therefore, we conclude that  a  chemical and 
spatial  reorganization of macrophage surface glycolipids occurs in response to 
tumoricidal activation and inflammation. 
It  is  well established  that  the accessibility of surface glycolipids to  external 
probes provides an indication of their degree of surface exposure (5, 23). The 
two most  widely used probes  for measuring glycolipid exposure are vectorial 
galactose  oxidase/NaB3H4  labeling  and  antibody binding.  Galactose  oxidase/ 
NaB3H4 labeling was the method of choice in this study, since it detects a broader 
spectrum of glycolipids and it is not limited by technical considerations such as 
antigen  concentration.  In  the  present  work,  we  minimized  the  possibility  of 
labeling internal membrane compartments by performing the labeling procedure 
at 4 °C (21). It is worth mentioning, however, that we did observe similar results 
in the experiments in which the macrophages were labeled at 37°C. 
The  biochemical  basis  for differences in  glycolipid exposure has  not  been 
elucidated in detail for any system, although proteins (5) and other carbohydrates 
(24) have been implicated as factors influencing the degree of glycolipid expo- 
sure. Differences in the glycolipid structure itself may also affect exposure (23). 
The alterations in surface exposure observed in the present study do not appear 
to result from a nonspecific increase in accessibility to galactose oxidase/NaBaH4 
labeling  in  TG-elicited and  tumoricidally activated macrophages.  This  is  evi- 
denced  by  the  observation  that  GMx  is  labeled  on  the  surface  of resident 
macrophages while asialo GM1, although present, is not accessible to labeling on 
these macrophages. Rather, our results provide evidence for a selective exposure MERCUR10  ET  AL.  1123 
of specific glycolipids. The differences in exposure may relate to alterations in 
surface polypeptides (25) and fatty acids (26,  27)  that have been reported to 
occur in activated macrophages. 
An  intriguing  observation  is  that  TG-elicited  and  tumoricidally  activated 
macrophages contain a third GMa species, or subtype, apparently not present in 
resident  macrophages.  The  possible  functional implications of this  additional 
subtype are unclear.  We are currently in  the process of obtaining additional 
structural information on these individual GM1  species, which should provide 
insight into the biochemical basis of the alterations in glycolipid composition. 
The biochemical and immunological data presented in this study demonstrate 
convincingly that asialo GM~ is present in the mouse peritoneal macrophage, and 
that it is accessible to labeling on the surface of TG-elicited and tumoricidally 
activated macrophages but not on resident macrophages. Asialo GM1 has received 
considerable attention as a surface marker, particularly since it has been reported 
to be a selective marker for natural killer cells (8).  The presence of asialo GM~ 
on the surface of macrophages has been a matter of dispute (e.g., 6, 7), and no 
data  before  this  study  had  been  available  on  its  surface distribution  among 
populations of macrophages differing in their state of activation. One inherent 
problem in  many of these studies is  that  their conclusions have been derived 
largely on the basis of immunological data, using antibodies that have not been 
adequately characterized. The anti-asialo GMl  antibody used in our work has 
been well characterized and is known to react with asialo GM~ on the surface of 
mouse lymphocytes (19). 
In recent studies on macrophage activation, a major strategy undertaken has 
involved the identification of components that distinguish the surfaces of inflam- 
matory and tumoricidally activated macrophages from resident macrophages (1- 
4). Our results suggest that surface differences among macrophage populations 
need not necessarily be qualitative, but may also reside in the spatial organization 
of surface components. This possibility is supported by the differences in gan- 
glioside  exposure  observed  between  BCG-activated  and  TG-elicited  macro- 
phages, as well as by the selective exposure of asialo GM1 on the surface of BCG- 
activated and TG-elicited macrophages. Moreover, as will be reported elsewhere 
(Mercurio, A. M., G. A. Schwarting, and P. W.  Robbins, manuscript in prepa- 
ration) a spatial reorganization of surface glycolipids appears to accompany the 
in vitro acquisition of tumoricidal capacity by TG-elicited macrophages in  the 
presence of gamma interferon and LPS. It is interesting to speculate that a spatial 
reorganization of surface components could serve to increase the accessibility of 
those macrophage components required for effective tumor cell interactions. 
In summary, the results presented in this paper demonstrate that the glycolipid 
constitutents of the mouse peritoneal macrophage are dynamic structures exhib- 
iting specific chemical and spatial alterations in response to inflammation and 
tumoricidai activation. Moreover, taken together with our other recent work on 
protein-bound carbohydrates (28, 29), ~ the present data substantiate the hypoth- 
2 Mercurio, A. M., and P. W.  Robbins.  1984.  Marked structural alterations in a specific class of 
protein-bound surface carbohydrates--the  lactosaminoglycans--occur in response to inflammation 
and tumoricidal activation of mouse peritoneal macrophages. Manuscript submitted for publication. 1124  GLYCOLIPIDS  OF  THE  MOUSE PERITONEAL MACROPHAGE 
esis  that  macrophage  activation  is  accompanied  by  widespread  alterations  in 
surface carbohydrates. 
Summary 
We have characterized the major glycolipid constituents of the mouse perito- 
neal macrophage, and have demonstrated that alterations in the amount and in 
the accessibility of specific glycolipid species to galactose oxidase/NaBSH4 label- 
ing, an indicator of glycolipid surface exposure, occur in response to inflamma- 
tion and as a  consequence of activation to a  tumoricidal state. The key findings 
are:  (a)  Asiaio GM1,  a  major neutral  glycolipid constituent of all  macrophage 
populations examined, is accessible to galactose oxidase/NaBSH4 labeling on the 
surface  of TG-elicited  and  BCG-activated  macrophages  but  not  on  resident 
macrophages; (b) GM~ is the predominant ganglioside constituent of the mouse 
macrophage. Resident macrophages contain two distinct GM~ species, as deter- 
mined by cholera toxin  binding,  while TG-elicited and  BCG-activated macro- 
phages contain an additional GM~ species. Differences in the relative amounts of 
these GM1 species, as well as in their accessibility to galactose oxidase/NaB~H4 
labeling, exist among the macrophage populations.  These observations suggest 
that both a  chemical and spatial reorganization of surface glycolipids occurs in 
response to inflammation and tumoricidal activation. 
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